You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Safety of A2A Adenosine Agonist for Treatment of Sepsis
SBC: ADENOSINE THERAPEUTICS, LLC Topic: N/ADESCRIPTION (provided by applicant): ATL146e is a synthetic small molecule developed by Adenosine Therapeutics, LLC (ATL) that acts as a selective agonist of the adenosine A2A receptor. ATL146e, sterile solution for intravenous (i.v.) bolus injection, is currently in Phase III of clinical development for use as a coronary vasodilator in pharmacodynamic stress imaging. ATL146e, when administered pa ...
STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
Safety of A2A Adenosine Agonist for Treatment of Sepsis
SBC: ADENOSINE THERAPEUTICS, LLC Topic: N/ADESCRIPTION (provided by applicant): ATL146e is a synthetic small molecule developed by Adenosine Therapeutics, LLC (ATL) that acts as a selective agonist of the adenosine A2A receptor. ATL146e, sterile solution for intravenous (i.v.) bolus injection, is currently in Phase III of clinical development for use as a coronary vasodilator in pharmacodynamic stress imaging. ATL146e, when administered pa ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
Microchips of Protein Kinase Substrates
SBC: ATACTIC TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): The long term goal of the proposed technology development is to take the current applications of the protein kinase (PK) substrate chips to the level suitable for proteome-scale applications and for developing clinical diagnostics. Recent years have witnessed dramatic expansion in our understanding of PK biology. In addition to the manifested intricate networks ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
SECONDARY PREVENTION OF ALCOHOLISM VIA COMPUTER SOFTWARE
SBC: Alcohol Self-control Program Topic: N/AN/A
SBIR Phase I 1990 Department of Health and Human Services -
Parallel DNA Assembling on MicroChip
SBC: ATACTIC TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): The increasing use of DNA as a molecular tool has ushered the technology of de novo synthesis of DNA back to the center stage of modern biology. We propose the development of a robust, ultra high-throughput (UHT) technology capable of genome-scale production of high fidelity synthetic DNA at about one percent of the cost and time of the current technologies. Ou ...
STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
Parallel DNA Assembling on MicroChip
SBC: ATACTIC TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): The increasing use of DNA as a molecular tool has ushered the technology of de novo synthesis of DNA back to the center stage of modern biology. We propose the development of a robust, ultra high-throughput (UHT) technology capable of genome-scale production of high fidelity synthetic DNA at about one percent of the cost and time of the current technologies. Ou ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
Advances in noninvasive, fluid-less alcohol measurements
SBC: Trutouch Technologies, Inc. Topic: N/ADESCRIPTION (provided by applicant): The objective of TruTouch Technologies, Inc. is to develop a new, more accurate, and cost-effective technology for noninvasive measurement of alcohol in human subjects. The TruTouch noninvasive measurement device offers the promise of reduced measurement time, elimination of safety concerns regarding handling of bodily fluids, and simplification of the alcohol ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
Label-Free NanOFET Microarrays with Embedded-Probe Nanocomposite Active Layers
SBC: NANOHMICS INC Topic: N/ADESCRIPTION (provided by applicant): Nanohmics, Inc. and Ambion, Inc. working in consortium with Dr. Susan Kauzlarich at the University of California Davis and Dr. Lynn Loo at the University of Texas at Austin propose to develop a Nanocomposite Organic Field-Effect Transistor (NanOFET) multiplex microarray platform for compact, label-free detection of oligonucleotide assays. The proposed method wi ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
MicroRNA Cellular Functions and Target Identification in Acute Myeloid Leukemia
SBC: AMBION DIAGNOSTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): The overall objective for our proposed research is to use the emerging field of miRNA research to identify therapeutic targets for acute myeloid leukemia (AML), a genetically and phenotypically heterogeneous disorder of the hematopoietic stem cells that is characterized by failure of blood cells to differentiate and over- production of stem cells. The currently ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
FLOURESCENT TOOLS FOR THE STUDY OF METALLOTHIONEIN
SBC: NEUROBIOTEX Topic: N/ADESCRIPTION (provided by applicant): We will deliver to life scientists fluorescent tools for the study of metallothionein and metallothionein- zinc signaling. Metallothionein-zinc signals have recently emerged as central step in many life-or-death signal pathways, including proliferation, apoptosis and metastasis. Arguably, MT-zinc signaling rivals calcium-calmodulin, IP3, and nitric oxide in ubi ...
STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health